JP2021536504A5 - - Google Patents
Info
- Publication number
- JP2021536504A5 JP2021536504A5 JP2021536672A JP2021536672A JP2021536504A5 JP 2021536504 A5 JP2021536504 A5 JP 2021536504A5 JP 2021536672 A JP2021536672 A JP 2021536672A JP 2021536672 A JP2021536672 A JP 2021536672A JP 2021536504 A5 JP2021536504 A5 JP 2021536504A5
- Authority
- JP
- Japan
- Prior art keywords
- hydrogen
- group
- alkyl
- alkynyl
- alkenyl
- Prior art date
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024059527A JP2024084794A (ja) | 2018-09-04 | 2024-04-02 | テトラサイクリン化合物を使用してマイコバクテリア感染症を処置する方法 |
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862726738P | 2018-09-04 | 2018-09-04 | |
| US62/726,738 | 2018-09-04 | ||
| US201862731410P | 2018-09-14 | 2018-09-14 | |
| US62/731,410 | 2018-09-14 | ||
| US201862746039P | 2018-10-16 | 2018-10-16 | |
| US62/746,039 | 2018-10-16 | ||
| US201862760131P | 2018-11-13 | 2018-11-13 | |
| US62/760,131 | 2018-11-13 | ||
| PCT/US2019/049368 WO2020051151A1 (en) | 2018-09-04 | 2019-09-03 | Methods of treating mycobacterial infections using tetracycline compounds |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024059527A Division JP2024084794A (ja) | 2018-09-04 | 2024-04-02 | テトラサイクリン化合物を使用してマイコバクテリア感染症を処置する方法 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021536504A JP2021536504A (ja) | 2021-12-27 |
| JPWO2020051151A5 JPWO2020051151A5 (https=) | 2022-09-06 |
| JP2021536504A5 true JP2021536504A5 (https=) | 2022-09-06 |
| JP7466544B2 JP7466544B2 (ja) | 2024-04-12 |
Family
ID=69722600
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021536672A Active JP7466544B2 (ja) | 2018-09-04 | 2019-09-03 | テトラサイクリン化合物を使用してマイコバクテリア感染症を処置する方法 |
| JP2024059527A Pending JP2024084794A (ja) | 2018-09-04 | 2024-04-02 | テトラサイクリン化合物を使用してマイコバクテリア感染症を処置する方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024059527A Pending JP2024084794A (ja) | 2018-09-04 | 2024-04-02 | テトラサイクリン化合物を使用してマイコバクテリア感染症を処置する方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US12161655B2 (https=) |
| EP (1) | EP3846805A4 (https=) |
| JP (2) | JP7466544B2 (https=) |
| KR (2) | KR20260036400A (https=) |
| CN (1) | CN113164456A (https=) |
| AU (2) | AU2019335203B2 (https=) |
| BR (1) | BR112021004057A2 (https=) |
| CA (1) | CA3111447A1 (https=) |
| MA (1) | MA53564A (https=) |
| MX (2) | MX2021002503A (https=) |
| PH (1) | PH12021550452A1 (https=) |
| SG (1) | SG11202102149SA (https=) |
| WO (1) | WO2020051151A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7840880B2 (ja) * | 2020-06-11 | 2026-04-06 | パラテック ファーマシューティカルズ，インコーポレイテッド | オマダサイクリンの結晶形態、その合成方法及びその使用方法 |
| TW202237116A (zh) * | 2020-12-02 | 2022-10-01 | 日商塩野義製藥股份有限公司 | 以組合細胞色素bc1抑制劑與克拉黴素或阿奇黴素為特徵之用於治療分枝桿菌感染之藥物 |
| JP2024511419A (ja) * | 2021-03-24 | 2024-03-13 | インスメッド インコーポレイテッド | 非結核性抗酸菌肺疾患を治療するための併用療法 |
| WO2025221846A1 (en) * | 2024-04-18 | 2025-10-23 | St. Jude Children's Research Hospital, Inc. | Compositions and methods for treating non-tuberculosis mycobacteria infections |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA009175B1 (ru) | 2000-07-07 | 2007-12-28 | Трастис Оф Тафтс Коллидж | Замещенные соединения миноциклина, фармацевтическая композиция и способ лечения чувствительного к тетрациклину состояния млекопитающего |
| US7553828B2 (en) | 2001-03-13 | 2009-06-30 | Paratek Pharmaceuticals, Inc. | 9-aminomethyl substituted minocycline compounds |
| US20060194773A1 (en) | 2001-07-13 | 2006-08-31 | Paratek Pharmaceuticals, Inc. | Tetracyline compounds having target therapeutic activities |
| EP2311451A1 (en) | 2002-03-08 | 2011-04-20 | Paratek Pharmaceuticals, Inc. | Amino-methyl substituted tetracycline compounds |
| PT2271348T (pt) * | 2008-03-28 | 2018-04-16 | Paratek Pharm Innc | Formulação de comprimido oral de composto de tetraciclina |
| TWI680117B (zh) | 2008-05-19 | 2019-12-21 | 派洛泰克藥物股份有限公司 | 四環素化合物之甲苯磺酸鹽及同素異形體 |
| KR101732084B1 (ko) | 2011-07-26 | 2017-05-02 | 케이비피 바이오사이언시즈 씨오., 엘티디. | 9-아미노메틸 치환된 테트라사이클린 화합물 |
| JP2015527403A (ja) | 2012-09-11 | 2015-09-17 | メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． | Ｈｉｖプロテアーゼ阻害剤 |
| CA3018872A1 (en) * | 2016-03-24 | 2017-09-28 | Paratek Pharmaceuticals, Inc. | Methods of treating a bacterial infection in a subject at risk of developing c. difficile infection |
| JP2019514952A (ja) * | 2016-05-02 | 2019-06-06 | パラテック ファーマシューティカルズ，インコーポレイテッド | ９−アミノメチルミノサイクリン化合物及び尿路感染症（ｕｔｉ）の処置におけるその使用方法 |
| TW202206081A (zh) * | 2016-08-03 | 2022-02-16 | 美商派瑞泰Ｓｐｖ２有限公司 | ９—胺甲基米諾四環素化合物及其用途 |
| GB201615693D0 (en) * | 2016-09-15 | 2016-11-02 | Combinatorx Infection Ltd | Combinations |
-
2019
- 2019-09-03 EP EP19858573.9A patent/EP3846805A4/en active Pending
- 2019-09-03 US US17/273,034 patent/US12161655B2/en active Active
- 2019-09-03 AU AU2019335203A patent/AU2019335203B2/en active Active
- 2019-09-03 BR BR112021004057-9A patent/BR112021004057A2/pt unknown
- 2019-09-03 MA MA053564A patent/MA53564A/fr unknown
- 2019-09-03 KR KR1020267005925A patent/KR20260036400A/ko active Pending
- 2019-09-03 CN CN201980072989.8A patent/CN113164456A/zh active Pending
- 2019-09-03 CA CA3111447A patent/CA3111447A1/en active Pending
- 2019-09-03 KR KR1020217009806A patent/KR102933150B1/ko active Active
- 2019-09-03 SG SG11202102149SA patent/SG11202102149SA/en unknown
- 2019-09-03 WO PCT/US2019/049368 patent/WO2020051151A1/en not_active Ceased
- 2019-09-03 MX MX2021002503A patent/MX2021002503A/es unknown
- 2019-09-03 JP JP2021536672A patent/JP7466544B2/ja active Active
-
2021
- 2021-03-02 MX MX2024008671A patent/MX2024008671A/es unknown
- 2021-03-03 PH PH12021550452A patent/PH12021550452A1/en unknown
-
2024
- 2024-04-02 JP JP2024059527A patent/JP2024084794A/ja active Pending
- 2024-10-30 US US18/932,596 patent/US20250332178A1/en active Pending
-
2025
- 2025-09-18 AU AU2025234215A patent/AU2025234215A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021536504A5 (https=) | ||
| US10653619B2 (en) | Drug depots for treatment of pain and inflammation | |
| JP2019522039A5 (https=) | ||
| KR101307650B1 (ko) | 구역에 대한 경피 방법 및 패치 | |
| AU2025234215A1 (en) | Methods of treating mycobacterial infections using tetracycline compounds | |
| CN107072885B (zh) | 用于治疗种植体周围炎的方法 | |
| JP2017535546A5 (https=) | ||
| US9956319B2 (en) | Compositions useful as antibiofilm or antimicrobial agents and methods using same | |
| JPWO2020051151A5 (https=) | ||
| WO2015112977A1 (en) | Antimicrobial formulations and applications thereof | |
| Yao et al. | Efficacy of teicoplanin in two dosage regimens for experimental endocarditis caused by a beta-lactamase-producing strain of Enterococcus faecalis with high-level resistance to gentamicin | |
| US9849126B2 (en) | Sterile otic formulations | |
| McKendrick et al. | Cefotaxime in septicaemia including typhoid fever | |
| Burgos et al. | The activity of several newer antimicrobials against logarithmically multiplying M. leprae in mice | |
| Aperis et al. | Corynebacterium minutissimum endocarditis: a case report and review | |
| RU2021106524A (ru) | Способы лечения микобактериальных инфекций с применением тетрациклиновых соединений | |
| US12576049B1 (en) | Onychomycosis treatment methods | |
| CN101180018B (zh) | 用于治疗恶心的经皮的方法和贴片 | |
| TWI731944B (zh) | 移植病患之治療 | |
| US12576189B2 (en) | Nerve grafts containing regenerative compounds, methods of making the same, and methods of treatment using the same | |
| Berry et al. | A new method for the treatment of chronic fungal meningitis: continuous infusion into the cerebrospinal fluid for coccidioidal meningitis | |
| RU2831120C2 (ru) | Способы лечения микобактериальных инфекций с применением тетрациклиновых соединений | |
| EP4422616A1 (en) | Human efficacious dose and dosage schedule of spr720 | |
| HUP0400916A2 (hu) | Transzdermális terápiás készítmény a gyapjú- és hajhullás megelőzésére és/vagy kezelésére | |
| Safdar et al. | Clinical microbiological case: refractory chest wall infection following reconstructive surgery in a patient with relapsed lung cancer |